NDC 70594-035-01 - Tigecycline
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70594-035
- Requested NDC
- 70594-035-01
- Package NDCs from labels
- 70594-035-01, 70594-035-02
- Manufacturer
- Xellia Pharmaceuticals USA LLC | Xellia Pharmaceuticals ApS
- Effective date
- 2020-03-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tigecycline - Xellia Pharmaceuticals USA LLC | Xellia Pharmaceuticals ApS | Xellia Pharmaceuticals USA LLC | Xellia Pharmaceuticals ApS | 2020-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70594-035-01 | EA - Each | 70594-035 | f5826f79-7dc7-4c11-a27f-53d8eed35a7a | 1 | 2020-08-06 |
| 70594-035-02 | EA - Each | 70594-035 | d579f638-46bf-495b-92f0-67d32d983dc2 | 1 | 2020-08-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tigecycline | TIGECYCLINE | Meitheal Pharmaceuticals Inc. | 6e9a34af-8dee-4ba2-9157-2f5cb46958a9 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | 70JE2N95KR |
| Tigecycline | TIGECYCLINE | Apotex Corp | 230484a8-408c-dcc1-d0c4-d9dd9a46831b | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | 70JE2N95KR |
| Tygacil | TIGECYCLINE | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2ccdb48e-c14a-4eeb-348c-4920ccfd7465 | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | 70JE2N95KR |
| Tygacil | TIGECYCLINE | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | fd826e47-1b77-4ffd-bb22-fda3379903b0 | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | 70JE2N95KR |
| Tigecycline | TIGECYCLINE | Meitheal Pharmaceuticals Inc. | 4cbefeb0-7d63-4c49-9906-384acc53dd15 | 2025-09-02 | Boxed warning, Warnings, Adverse reactions | 70JE2N95KR |
| Tigecycline | TIGECYCLINE | Sandoz Inc | 50605463-2dc2-4b27-bc51-4d87bb9a8539 | 2025-08-24 | Boxed warning, Warnings, Adverse reactions | 70JE2N95KR |
| Tigecycline | TIGECYCLINE | Eugia US LLC | dd58e0c3-d8a8-4cf2-96f8-9dd08f309579 | 2025-04-18 | Boxed warning, Warnings, Adverse reactions | 70JE2N95KR |
| Tigecycline | TIGECYCLINE | Amneal Pharmaceuticals LLC | 8450bd15-2b06-4fc7-b302-9021312e3f0d | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | 70JE2N95KR |
| ca90cb96-f73c-4e42-ad2e-1e5afa7afffc | 4183ef14-7db7-4fe3-978b-a35b1d29f378 | 2023-06-27 | Boxed warning, Warnings, Adverse reactions | 4183ef14-7db7-4fe3-978b-a35b1d29f378 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.